Factors Influencing Illness Uncertainty in Parents of Children with Congenital Adrenal Hyperplasia in a Developing Country: A Cross-sectional Study

Overview

Journal Belitung Nurs J

Date 2023 Jul 20

PMID 37469639

Authors

Irene Astrid Larasati

Fanti Saktini

Tri Indah Winarni

Annastasia Ediati

Agustini Utari

Affiliations

Soon will be listed here.

Abstract

Background: Illness uncertainty in parents of children with congenital adrenal hyperplasia (CAH) refers to parents' inability to create meaning in events related to their children having CAH. This may influence their role in caring for children with CAH.

Objective: The study aimed to determine factors associated with illness uncertainty experienced by parents of children with CAH in a developing country.

Methods: A cross-sectional study was conducted on 80 parents (43 mothers and 37 fathers) of children with CAH, selected using consecutive sampling methods. The Parent's Perception of Uncertainty Scale (PPUS) was used to measure the illness uncertainty levels. Data were collected from March 2020 to October 2020. Independent -test and chi-square test were used to determine factors (parent's gender, age, educational level, monthly household income, number of children with CAH, history of child death due to CAH, child's age when first diagnosed with CAH, duration of therapy, gender change, type of CAH (salt wasting/SW or simple virilizing/SV), current gender, and genitoplasty) influencing illness uncertainty in parents.

Results: The mean scores of PPUS were 42.3 ± 12.91, and the majority of parents had a low PPUS score (49; 61%). Parents of children with SW-CAH showed higher uncertainty (44.2 ± 12.77) than those with SV-CAH (32.6 ± 8.86; = 0.003). Parents who lost their children due to CAH were more likely to report a moderate illness uncertainty than parents who never experienced child mortality due to CAH (χ(1, 80) = 4.893; = 0.027).

Conclusion: The factors significantly affecting uncertainty in parents of children with CAH determined in this study might help healthcare professionals, including nurses, to play a pivotal role in giving pertinent information regarding their children's health, disease, and therapy to help manage parental uncertainty.

Citing Articles

Trajectories of illness uncertainty among parents of children with atypical genital appearance due to differences of sex development.

Traino K, Ciciolla L, Perez M, Chaney J, Welch G, Baskin L J Pediatr Psychol. 2024; 49(8):559-570.

PMID: 38857449 PMC: 11335143. DOI: 10.1093/jpepsy/jsae043.

References

Juniarto A, Ulfah M, Ariani M, Utari A, Faradz S . Phenotypic Variation of 46,XX Late Identified Congenital Adrenal Hyperplasia among Indonesians. J ASEAN Fed Endocr Soc. 2021; 33(1):6-11. PMC: 7784163. DOI: 10.15605/jafes.033.01.02. View

Perez M, Delozier A, Aston C, Austin P, Baskin L, Chan Y . Predictors of Psychosocial Distress in Parents of Young Children with Disorders of Sex Development. J Urol. 2019; 202(5):1046-1051. PMC: 6946548. DOI: 10.1097/JU.0000000000000424. View

McConkie-Rosell A, Hooper S, Pena L, Schoch K, Spillmann R, Jiang Y . Psychosocial Profiles of Parents of Children with Undiagnosed Diseases: Managing Well or Just Managing?. J Genet Couns. 2018; 27(4):935-946. PMC: 6028305. DOI: 10.1007/s10897-017-0193-5. View

Davies R . New understandings of parental grief: literature review. J Adv Nurs. 2004; 46(5):506-13. DOI: 10.1111/j.1365-2648.2004.03024.x. View

Odenwald B, Dorr H, Bonfig W, Schmidt H, Fingerhut R, Wildner M . Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase-Deficiency: 13 Years of Neonatal Screening and Follow-up in Bavaria. Klin Padiatr. 2015; 227(5):278-83. DOI: 10.1055/s-0035-1554639. View

Pezzuti I, Barra C, Mantovani R, Januario J, Silva I . A three-year follow-up of congenital adrenal hyperplasia newborn screening. J Pediatr (Rio J). 2014; 90(3):300-7. DOI: 10.1016/j.jped.2013.09.007. View

Speiser P, Arlt W, Auchus R, Baskin L, Conway G, Merke D . Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018; 103(11):4043-4088. PMC: 6456929. DOI: 10.1210/jc.2018-01865. View

Gidlof S, Wedell A, Guthenberg C, von Dobeln U, Nordenstrom A . Nationwide neonatal screening for congenital adrenal hyperplasia in sweden: a 26-year longitudinal prospective population-based study. JAMA Pediatr. 2014; 168(6):567-74. DOI: 10.1001/jamapediatrics.2013.5321. View

Molzon E, Brannon E, Fedele D, Grant D, Suorsa K, Mullins L . Factor structure of the parent perception of uncertainty scale in parents of children with cancer. Psychooncology. 2014; 23(12):1435-8. DOI: 10.1002/pon.3574. View

10.

Mishel M . Uncertainty in illness. Image J Nurs Sch. 1988; 20(4):225-32. DOI: 10.1111/j.1547-5069.1988.tb00082.x. View

11.

Suorsa K, Mullins A, Tackett A, Reyes K, Austin P, Baskin L . Characterizing Early Psychosocial Functioning of Parents of Children with Moderate to Severe Genital Ambiguity due to Disorders of Sex Development. J Urol. 2015; 194(6):1737-42. PMC: 5889973. DOI: 10.1016/j.juro.2015.06.104. View

12.

Armstrong K, Benedict Yap A, Chan-Cua S, Craig M, Cole C, Dung V . We All Have a Role to Play: Redressing Inequities for Children Living with CAH and Other Chronic Health Conditions of Childhood in Resource-Poor Settings. Int J Neonatal Screen. 2020; 6(4). PMC: 7711668. DOI: 10.3390/ijns6040076. View

13.

Stroebe M, Folkman S, Hansson R, Schut H . The prediction of bereavement outcome: development of an integrative risk factor framework. Soc Sci Med. 2006; 63(9):2440-51. DOI: 10.1016/j.socscimed.2006.06.012. View

14.

Sirki K, Saarinen-Pihkala U, Hovi L . Coping of parents and siblings with the death of a child with cancer: death after terminal care compared with death during active anticancer therapy. Acta Paediatr. 2000; 89(6):717-21. DOI: 10.1080/080352500750044070. View

15.

Witchel S . Congenital Adrenal Hyperplasia. J Pediatr Adolesc Gynecol. 2017; 30(5):520-534. PMC: 5624825. DOI: 10.1016/j.jpag.2017.04.001. View

16.

Hullmann S, Fedele D, Wolfe-Christensen C, Mullins L, Wisniewski A . Differences in adjustment by child developmental stage among caregivers of children with disorders of sex development. Int J Pediatr Endocrinol. 2011; 2011(1):16. PMC: 3229437. DOI: 10.1186/1687-9856-2011-16. View

17.

Tsuji A, Konishi K, Hasegawa S, Anazawa A, Onishi T, Ono M . Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study. BMC Pediatr. 2015; 15:209. PMC: 4681082. DOI: 10.1186/s12887-015-0529-y. View

18.

Idris A, Chandran V, Syed Zakaria S, Rasat R . Behavioural outcome in children with congenital adrenal hyperplasia: experience of a single centre. Int J Endocrinol. 2014; 2014:483718. PMC: 3995314. DOI: 10.1155/2014/483718. View

19.

Bizic M, Jeftovic M, Pusica S, Stojanovic B, Duisin D, Vujovic S . Gender Dysphoria: Bioethical Aspects of Medical Treatment. Biomed Res Int. 2018; 2018:9652305. PMC: 6020665. DOI: 10.1155/2018/9652305. View

20.

Ediati A, Juniarto A, Birnie E, Okkerse J, Wisniewski A, Drop S . Social stigmatisation in late identified patients with disorders of sex development in Indonesia. BMJ Paediatr Open. 2018; 1(1):e000130. PMC: 5862183. DOI: 10.1136/bmjpo-2017-000130. View